Chemical Structure
Sildenafil Citrate Tablet, Film Coated
Product Images NDC 13668-186
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 13668-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1
This appears to be a graph displaying the systolic blood pressure (in mmHg) data at various time points (in minutes) before and after administering Sildenafil 100mg and a placebo. There are two data lines plotted, one for the Sildenafil group and the other for the placebo group. The graph seems to suggest that Sildenafil had no significant impact on systolic blood pressure over the given time frame.*
Figure 2
This appears to be a graph showing the change in systolic blood pressure (SBP) over time (in hours) after taking Doxazosin alone or Doxazosin with Sildenafil 25mg. The graph shows that Doxazosin alone had a larger increase in SBP compared to Doxazosin with Sildenafil.*
Figure 3
This is a graph showing the change in SBP (systolic blood pressure) in mmHG over time post dose in hours. The graph compares the effects of Doxazosin + Placebo versus Doxazosin + Sildenafil 50 mg. The values on the y-axis range from 0 to 40 and on the x-axis from 1 to 8.*
Figure 4
This appears to be a figure or chart without any context or explanation, showing two lines representing the effects of two different treatments (Doxazosin + Sildenafil 100 mg and Doxazosin + Placebo) over a period of time (hours) on a vertical axis labeled with mmHg. As such, a useful description cannot be generated without additional information.*
Figure 5
Not available.*
Figure 6 1
This appears to be a chart or table with various percentages and scores. It includes data points for patients at an endpoint and a baseline score. However, without any additional context, it is not possible to determine what these percentages and scores represent or what they are being used for.*
Figure 6 2
Figure 7
This is a data table showing the percentage of patients reporting improvement after taking different dosages of sildenafil citrate, along with a placebo. The dosages tested were 25mg, 50 mg, and 100 mg. The table shows that the percentage of patients reporting improvement decreased as the dosage increased, except for the placebo group which had a 100% reported improvement rate.*
Label 100mg 30s
This is a description of a medication named sidenafi citrate. Each film-coated tablet contains 100 mg of sidenafl. The tablets are to be stored in a tight container with a child-resistant closure at a temperature between 20° to 25°C (68° to 77°F). The usual dosage is 100 {11]1). The medication is manufactured in India by TORRENT PHARMACEUTICALS LTD. and distributed by TORRENT PHARMA INC. in Levitiown, PA 19057. More information about the medication can be found in the accompanying prescribing information.*
Label 25mg 30s
This is a description of Sildenafil tablets, which are film-coated tablets containing 25mg of Sildenafil citrate USP 30. These are manufactured by Torrent Pharmaceuticals LTD. The tablets should be stored within a tight container with a child-resistant closure at an ideal temperature of 20°C to 25°C. The recommended dosage must be verified before use. The prescription number is available, and it is only available with a doctor's prescription.*
Label 50mg 30s
Torrent Logo Copy
Torrent Logo
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
